tiprankstipranks
Trending News
More News >
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market

Lyell Immunopharma (LYEL) Income Statement

Compare
147 Followers

Lyell Immunopharma Income Statement

Last quarter (Q3 2025), Lyell Immunopharma's total revenue was $15.00K, a decrease of -55.88% from the same quarter last year. In Q3, Lyell Immunopharma's net income was $-38.85M. See Lyell Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 61.00K$ 130.00K$ 84.68M$ 10.65M$ 7.76M
Gross Profit
$ 61.00K$ 130.00K$ 84.68M$ 10.65M$ 7.76M
Operating Expenses
$ 358.82M$ 247.14M$ 271.74M$ 225.43M$ 219.69M
Depreciation and Amortization
$ 19.63M$ 20.25M$ 18.02M$ 13.62M$ 4.29M
EBITDA
$ -200.64M$ -226.76M$ -169.04M$ -201.15M$ -215.43M
Operating Income
$ -358.75M$ -247.01M$ -187.06M$ -214.78M$ -211.94M
Other Income/Expenses
$ 15.76M$ 12.38M$ 3.94M$ -35.44M$ 7.46M
Pretax Income
$ -342.99M$ -234.63M$ -183.12M$ -250.22M$ -204.47M
Net Income
$ -342.99M$ -234.63M$ -183.12M$ -250.22M$ -204.47M
Per Share Metrics
Basic EPS
$ -1.31$ -0.93$ -0.74$ -1.03$ -0.84
Diluted EPS
$ -1.31$ -0.93$ -0.74$ -1.03$ -0.84
Weighted Average Shares Outstanding
13.07M 12.55M 12.35M 12.14M 12.33M
Weighted Average Shares Outstanding (Diluted)
13.07M 12.55M 12.35M 12.14M 12.33M
Currency in USD

Lyell Immunopharma Earnings and Revenue History